Llaneras, J., Barciela, M. R., Pericas, E., Boixareu, N., Navarro, J., Esteban, J. I., . . . Esteban, R. (2020). THU417 - Impact of the universal access to direct-acting antivirals in the profile of hepatitis C treated patients. Journal of Hepatology, 73, S344. https://doi.org/10.1016/S0168-8278(20)31189-2
Chicago Style (17th ed.) CitationLlaneras, Jordi, et al. "THU417 - Impact of the Universal Access to Direct-acting Antivirals in the Profile of Hepatitis C Treated Patients." Journal of Hepatology 73 (2020): S344. https://doi.org/10.1016/S0168-8278(20)31189-2.
MLA (9th ed.) CitationLlaneras, Jordi, et al. "THU417 - Impact of the Universal Access to Direct-acting Antivirals in the Profile of Hepatitis C Treated Patients." Journal of Hepatology, vol. 73, 2020, p. S344, https://doi.org/10.1016/S0168-8278(20)31189-2.